Community/Retail

The generic pharmaceutical industry will continue to work with the FDA and other stakeholders to make sure that drug labels protect patient safety, align with federal laws, and do not hinder patient access to more affordable generic medicines.

A pharmacist in Cleveland, Tennessee, has surrendered her license following an investigation into her compounding pharmacy's use of potentially unsafe ingredients.

The doors to King's Daughters Medical Center (KDMC) will open for 2 postgraduate year 1 residents.

The enhanced system gives eye care professionals the ability to safely deliver an intraocular lens through incisions as small as 2.2 mm.

Commonly cited estimates on how easily newly infected patients transmit HIV may be vastly overstated.

States that expanded Medicaid coverage under the Affordable Care Act have seen a 23% increase in the number of newly diagnosed diabetes patients.

The collaboration aims to educate adults with diabetes about their increased risk for potentially serious health problems, including pneumococcal pneumonia, influenza, and hepatitis B.

More than 350 pharmacy advocates from 44 states met with members of Congress during NACDS RxIMPACT Day on Capitol Hill.

Strategic Collaboration Designed to Develop New Technologies that Offer Surgeons and Health Care Systems Greater Accuracy, Cost Efficiency and Better Outcomes for Patients

Zyprexa Relprevv's label and recommended use remain unchanged.

Forum provides platform for discussion on current and future care of patients living with Gaucher disease.

The initiative will establish network to learn and share best practices to provide better quality and more efficient care.

Students who have not yet obtained a bachelor's degree can now apply to the Cedarville University School of Pharmacy.

The FDA today approved a vaccine for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis for children aged 4 to 6 years.

Cancer drug prices have increased 10% each year since 1995, even after adjusting for inflation and incremental health benefits.

As part of the initiative, PAPCC will run print and digital advertising in beltway media outlets over the course of the Congressional calendar.

The FDA today approved anthrax immune globulin intravenous (Anthrasil) for the treatment of inhalational anthrax in combination with appropriate antibiotics.

The FDA has approved a new treatment for 1 of the most common diabetic eye diseases.

Epocrates and Micromedex may be the go-to references for drug information, but new tools are coming to the market.

Treatment with Genzyme's Cerdelga® (eliglustat) capsules maintains hematological and organ volume stability in adults with Gaucher disease type 1 previously stabilized with intravenous enzyme replacement therapy.

Patients with limited life expectancy may see improvement in their quality of life if they stop taking statins.

The collaboration also aims to better understand how the function of beta cells declines in diabetes and research findings will be made available to the broader scientific community through peer-reviewed publications.

NABP launched .pharmacy to provide a means for easily identifying safe and legal online pharmacies and related resources.

The first-ever NACDS RxIMPACT key contact award was presented to Shopko's Ryan Swensen.

Few studies have examined whether compulsory community treatment meets its goals of improved clinical outcomes, better social functioning, and reduced health service use.

For many students, spring break invokes thoughts of the beach, sunny weather, and relaxation. But for researchers from Florida Atlantic University and the University of Miami, it signals a spike in fatal car accidents.

The alert warns of potentially dangerous mix-ups between 2 relatively new presentations of older medications.

Many children with food allergies develop micronutrient deficiencies.

Shire's ADHD treatment, lisdexamfetamine dimesylate (Vyvanse), is now available in a 10-mg titration dose.